Identification and Evaluation of Small Molecule Pan-Caspase Inhibitors in Huntington's Disease Models
- 1 November 2010
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 17 (11) , 1189-1200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Composite Primary Neuronal High-Content Screening Assay for Huntington’s Disease Incorporating Non-Cell-Autonomous InteractionsSLAS Discovery, 2010
- Human Caspases: Activation, Specificity, and RegulationJournal of Biological Chemistry, 2009
- Identification of a New Class of Nonpeptidic Inhibitors of CruzainJournal of the American Chemical Society, 2008
- Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumainBioorganic & Medicinal Chemistry Letters, 2007
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's diseaseCell Death & Differentiation, 2004
- Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificityCell Death & Differentiation, 2003
- Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear InclusionsMolecular Cell, 2002
- Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal CellsJournal of Biological Chemistry, 2000
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997